The Lifetime Medical Cost Burden of Overweight and Obesity: Implications for Obesity Prevention
Abstract
This study quantifies age-specific and lifetime costs for overweight (BMI: 25-29.9), obese I (BMI: 30-34.9), and obese II/III (BMI: >35) adults separately by race/gender strata. We use these results to demonstrate why private sector firms are likely to underinvest in obesity prevention efforts. Not only does the existence of Medicare reduce the economic burden that obesity imposes on private payers, but, from the perspective of a 20-year-old obese adult, the short-term costs of obesity are small. This suggests that legislation that subsidizes wellness programs and/or mandates coverage for obesity treatments might make all firms better off. Ironically, Medicare has a greater incentive to prevent obesity because when an obese 65 year old enters the program, his/her costs are immediate and higher than costs for normal weight individuals.Keywords
This publication has 16 references indexed in Scilit:
- Counting the costs of overweight and obesity: modeling clinical and cost outcomesCurrent Medical Research and Opinion, 2006
- Excess Deaths Associated With Underweight, Overweight, and ObesityJAMA, 2005
- The Health And Cost Consequences Of Obesity Among The Future ElderlyHealth Affairs, 2005
- Relation of Body Mass Index in Young Adulthood and Middle Age to Medicare Expenditures in Older AgeJAMA, 2004
- State‐Level Estimates of Annual Medical Expenditures Attributable to Obesity*Obesity Research, 2004
- Methods of Estimating Years of Life Lost Due to Obesity—ReplyJAMA, 2003
- Years of Life Lost Due to ObesityJAMA, 2003
- Lifetime Health and Economic Consequences of ObesityArchives of internal medicine (1960), 1999
- Consequences of the Use of Different Measures of Effect to Determine the Impact of Age on the Association between Obesity and MortalityAmerican Journal of Epidemiology, 1999
- The direct health care costs of obesity in the United States.American Journal of Public Health, 1999